+ All Categories
Home > Documents > PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

Date post: 12-Jan-2016
Category:
Upload: joseph-gardner
View: 263 times
Download: 4 times
Share this document with a friend
Popular Tags:
27
PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)
Transcript
Page 1: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

PHARMACOLOGYCNS 2

ANXIOLYTICS, HYPNOTICS AND SEDATIVES

SAMUEL AGUAZIM( MD)

Page 2: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

Tolerance and Dependence

• Tolerance is a physiology state characterized by a reduced drug effect with repeated use of the drug. Higher doses are needed to produce the same effect.

• Cross-tolerance means that individuals tolerant to one drug will be tolerant to other drugs in the same class, but not to drugs in other classes

Page 3: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

Tolerance and Dependence

• Dependence is characterized by signs and symptoms of withdrawal when drug levels fall.

• Cross-dependence means that individuals dependent to one drug will be dependent to other drugs in the same class, but not to drugs in other classes

• Note: Cross-tolerance and Cross-dependence occur between all of the CNS sedatives, including the barbiturates, benzodiazepines and ethanol.

Page 4: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

ANXIOLYTICS, HYPNOTICS AND SEDATIVES

• Define anxiety: an unpleasant emotional state consisting of apprehension, tension and feelings of danger, without a real or logical cause.

• Physical symptoms include: tachycardia, tachypnea, sweating, trembling and weakness

Page 5: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

ANXIOLYTICS, HYPNOTICS AND SEDATIVES

• A sedative drug decreases activity, moderates excitement, and calms the recipient.

• B. A hypnotic drug produces drowsiness and facilitates the onset and maintenance of a state of sleep that resembles natural sleep, and from which the patient can be easily aroused.

• C. An anxiolytic drug reduces anxiety.

Page 6: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)
Page 7: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

Organization of Class

• Sedative-hypnotics are drugs which depress or slow down the body's functions. Often these drugs are referred to as tranquilizers and sleeping pills or sometimes just as sedatives.

• They depress behavior, moderate excitement, induce calmness, and may produce drowsiness or even loss of consciousness. The sedative-hypnotics are used clinically as anti-anxiety agents, muscle relaxants, sleep inducers, anti-epileptics, and as preanesthetic medications.

Page 8: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

Major classes of drugs used to treat anxiety?

• Benzodiazepines- the most frequently used drugs for anxiety

• Azaspirones- for example, buspirone• Carbamates- for example, meprobamate• Barbiturates- rarely used today because of

severe side effects and a low therapeutic index. These drugs have generally been replaced by the benzodiazepines.

Page 9: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

BENZODIAZEPINES

• SHORT –ACTING (2-8 HOURS)• OXAZEPAM( serax)• Clonazepam(klonopin)• Midazolam (versed)• Triazolam (halcion)• INTERMEDIATE ACTING ( 10-20 HOURS)• Temazepam (restoril)• Lorazepam ( ativan)• Alprazolam ( xanax)

Page 10: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

BENZODIAZEPINES

• LONG- ACTING ( 1-3 DAYS)• Chlordiazepoxide ( librium)• Diazepam ( valium)• Flurazepam ( dalmane)• NEUROTRANSMITTER INVOLVED• GABA( y-aminobutyric acid) is the

major inhibitory neurotransmitter of the CNS.

Page 11: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

Mechanism of action

• Barbiturates and benzodiazepines act similarly to produce depression of central nervous system function and behavior.

• Barbiturates enhance the function of y-aminobutyric (GABA)in the CNS.

• Benzodiazepines bind to a specific site associated with GABAд receptor which results in increased inhibition.

Page 12: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

WHAT ARE THE THERAPEUTIC INDICATIONS FOR BENZODIAZEPINES

• These drugs are used clinically as muscle relaxants and in the treatment of the following:

• Anxiety disorders• Panic disorders- alprazolam is the drug of choice• Status epilepticus- diazepam is the drug of choice• Sleep disorders• Insomnia- all benzodiazepines can be sedating but

lorazepam and temazepam are the most commonly used.

• Alcohol withdrawal- Chlordiazepoxide most commonly used.

Page 13: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

BENZODIAZEPINES

• What is their route of administration?• PO, IV or IM• Where are benzodiazepines metabolized?• They are metabolized in the liver and

excreted in urine.• Does dependence occur?• Yes. Prolonged use can result in

dependence. Abrupt discontinuation can result in withdrawal symptoms, including confusion, anxiety and agitation.

Page 14: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

What type of symptoms may a patient taking benzodiazepines

experience?• Drowsiness and confusion- the most

common side effects• Ataxia• Dizziness• Respiratory depression and death, if

taken with other CNS depressants such as ethanol.

Page 15: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

Anxiolytic and Sedative-Hypnotics

STAGES OF CNS DEPRESSION.

• With increasing dosage: • Calming or drowsiness {sedation} • Sleep {pharmacological hypnosis} • Unconsciousness • Surgical anesthesia • Coma • Fatal respiratory/cardiovascular depression

Page 16: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

Benzodiazepines antagonist: Flumazenil ( romazicon)

• MECHANISM OF ACTION OF FLUMAZENIL

• It is a competitive antagonist of benzodiazepines at the GABA A RECEPTOR.

• Clinical use: reversal of benzodiazepine sedation or overdose

• How long do the effects of Flumazenil last?

• Only 1 hour- repeat doses may be necessary for a heavily sedated patient to remain alert.

Page 17: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

AZASPIRONES: BUSPIRONE ( BuSpar)

• MECHANISM OF ACTION: It acts as a partial agonist of serotonin ( 5HT1A ) receptor.

• Clinical use of this drug. Buspirone is used for generalized anxiety; however, unlike benzodiazepines, its effects may take 2 weeks to become apparent.

• This drug metabolized by the liver and excreted in the urine.

• Buspirone differs from benzodiapines because it lacks muscle relaxant and anticonvulsant properties of the benzodiazepines

Page 18: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

What advantages does buspirone have over benzodiazepines?

• Minimal sedation• Low abuse potential• No overdose fatalities reported• No withdrawal symptoms• What toxic effects are associated with

buspirone?• Headache• Nausea• Dizziness

Page 19: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

CARBAMATES: MEPROBAMATE

• What is meprobamate’s mechanism of action? It is not well known.

• Clinical use: It is now virtually obsolete. In the past it was used primarily in the treatment of anxiety.

• What are the adverse effects?• Respiratory depression-major toxic effect• Hypotension• Shock• Heart failure

Page 20: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

BARBITURATES

• EXAMPLES OF BARBITURATES• PHENOBARBITAL (LUMINAL)- LONG ACTING• PENTOBARBITAL (NEMBUTAL )- SHORT ACTING• AMOBARBITAL ( AMYTAL)- SHORT ACTING• THIOPENTAL ( PENTOTHAL)- ULTRASHORT-

ACTING

Page 21: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

WHAT ARE THE THERAPEUTIC INDICATIONS FOR BARBITURATE ADMINISTRATION

• Induction of anesthesia- thiopental• Anticonvulsants- e.g, phenobarbital• Treatment of anxiety• Induction of hypnosis• Why are benzodiazepines favored

over barbiturates for the treatment of anxiety?

• Benzodiazepines have a much higher therapeutic index than do barbiturates

Page 22: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

BARBITURATES

• By what routes can barbiturates can be administered?

• IV, PO OR IM• What are the pharmacokinetic properties of

barbiturates?• they are metabolized in the liver and all

induce cytochrome P-450 and excreted in the urine

• Redistribution to other tissues determines the duration of action of thiopental.

Page 23: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

BARBITURATES

• Does barbiturate dependency occur?• Yes- abrupt cessation can lead to

severe withdrawal symptoms ( tremor, restlessness, nausea, seizures and cardiac arrest)

• Contraindication: not given to patients who have acute intermittent porphyria, because they increase porphyrin synthesis

Page 24: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

BARBITURATES

• What are the adverse effects of these drugs?

• Drowsiness and decreased motor control• Induction of the P-450 system• Addiction• Respiratory depression and coma in high

doses• Allergic reactions, especially in patients

with asthma

Page 25: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

OTHER SEDATIVES( benzodiazepine receptor agonist

• Zalephon, Zolpidem and eszopiclone are known as non-benzodiazepine receptors agonist ( NBBRAS)

• ZOLPIDEM (AMBEIN)• Describe this drugs clinical use• Treatment of insomnia (SHORT TERM)• What are its adverse effects?• Ataxia and Confusion

Page 26: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

CHLORAL HYDRATE

• CLINICAL USES:• HYPNOSIS• SEDATION ( in children)• Describe this drug’s adverse

effects.• Gastrointestinal distress• Unpleasant taste

Page 27: PHARMACOLOGY CNS 2 ANXIOLYTICS, HYPNOTICS AND SEDATIVES SAMUEL AGUAZIM( MD)

Melatonin Receptor Agonist

• Ramelteon is a selective agonist at the MT₁ and MT₂ subtypes of melatonin receptors.

• This drugs help one fall asleep 7-16 minutes faster.

• Side effect: dizziness, fatigue and somnolence


Recommended